This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Mahmoud Abou Alaiwa in Cystic Fibrosis Treatment
Introduction
Mahmoud Abou Alaiwa is an accomplished inventor based in Iowa City, IA. He has made significant contributions to the field of medical treatment, particularly in addressing cystic fibrosis airway disease. His innovative approach has led to the development of a unique therapeutic method that aims to improve the quality of life for patients suffering from this condition.
Latest Patents
Abou Alaiwa holds a patent for a method of treating cystic fibrosis airway disease. This patent, which is titled "Method of treating cystic fibrosis airway disease," describes a process that involves increasing the liquid pH on the airway surface of a tissue in a patient. The method comprises administering an effective amount of a therapeutic composition that includes tromethamine to the patient. This innovative treatment has the potential to enhance airway function and alleviate symptoms associated with cystic fibrosis.
Career Highlights
Mahmoud Abou Alaiwa is affiliated with the University of Iowa Research Foundation, where he conducts research and develops new therapeutic methods. His work is characterized by a commitment to improving patient outcomes through innovative solutions. With a focus on cystic fibrosis, Abou Alaiwa has dedicated his career to advancing medical science and providing hope to those affected by this challenging disease.
Collaborations
Abou Alaiwa collaborates with Joseph Zabner, a fellow researcher in the field. Their partnership exemplifies the importance of teamwork in scientific research and innovation. Together, they work towards enhancing the understanding and treatment of cystic fibrosis.
Conclusion
Mahmoud Abou Alaiwa's contributions to the treatment of cystic fibrosis through his patented method highlight the impact of innovation in medicine. His dedication to research and collaboration with peers underscores the importance of advancing healthcare solutions. Through his work, he continues to inspire hope for patients and contribute to the field of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile